evipedia.ai
← Back

Undenatured Type II Collagen for Health & Longevity

Created on 10/31/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Undenatured type II collagen is a dietary supplement from chicken breastbone cartilage, taken in milligram amounts to keep knees comfortable enough to stay active. Modest relief of knee osteoarthritis pain rests largely on maker-funded trials; the most rigorous independent trial found no benefit, and alongside structured exercise added value appears small and uncertain. Safety appears favorable in trials up to six months; the clearest danger is replacing rheumatoid arthritis medicine. (Full Review)

Protocol

Standard dose
40 mg UC-II once daily
About 10 mg undenatured collagen by the original assay, 1.2–2.3 mg by the revised assay
Time of day
Bedtime or morning
Bedtime with water in UC-II trials; no trial compared timing; single daily dose, split dosing not tested
Competing native collagen products
Doses not interchangeable
Native CT-II 40 mg, CN2 40 mg, water-soluble NEXT-II 3.2 mg, native collagen 10 mg
Time to effect
Knee osteoarthritis (UC-II)
About 60–90 days
Differences from placebo appeared
Knee osteoarthritis (Native CT-II)
By 4 weeks
Differences from placebo appeared
Flexibility in active adults
90–120 days
Flexibility gains with UC-II

Benefits

Contraindications
  • People with chicken, egg or fowl allergy
  • Pregnant or breastfeeding women
  • People with rheumatoid arthritis who would use it in place of disease-modifying therapy
    •
Key Interactions
  • Disease-modifying antirheumatic drugs (methotrexate, sulfasalazine, hydroxychloroquine): added to existing therapy, collagen gave no extra benefit
    •
Theoretical (inferred from mechanism)
  • Immunosuppressants and corticosteroids (prednisone, tacrolimus, cyclosporine, adalimumab): possibly reducing any benefit
  • Acid-suppressing drugs (omeprazole, pantoprazole, famotidine): unknown direction of effect
  • Pain relievers (ibuprofen, naproxen): additive pain relief
  • Other joint supplements (glucosamine, chondroitin, boswellia): possible additive symptom relief
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Loss of rheumatoid arthritis control when substituted for standard therapy; mild gastrointestinal complaints; allergic reaction in people allergic to chicken or egg; disease flares in rheumatoid arthritis
    •
  • Speculative:

Monitoring

Marker Target Why
WOMAC or KOOS knee score No established target; track change from own baseline Pain and function
Knee range of motion (degrees) About 0° extension to 135° flexion; track change from own baseline Flexibility
Urinary or serum CTX-II No established target; track change from own baseline Cartilage breakdown
Swollen and tender joint count (rheumatoid arthritis only) No established target; track change from own baseline Safety check: a rise stops or changes use

Cadence: Baseline, then at 3 and 6 months, then every 6–12 months while use continues; in rheumatoid arthritis, joint count monthly for the first 3 months

Qualitative Assessment

  • Joint comfort during and after exercise
  • Time before discomfort starts in usual activity
  • Morning stiffness duration
  • Ease of stairs, squatting and kneeling
  • Need for pain relievers
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.